ClinicalTrials.Veeva

Menu

Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy

S

SPGO Research Mannheim

Status

Unknown

Conditions

Carcinoma

Study type

Observational

Funder types

Industry

Identifiers

NCT02303353
REGONKO-01

Details and patient eligibility

About

The purpose of this registry is to evaluate the situation regarding ambulant therapy of cancer patients in different practices in Germany. It should provide insight into the implementation of schemes for cancer therapy predefined in the guidelines, the treatment of diverse adverse reactions and the counter measures taken. Thereby, potential differences in treatment and with that differences in quality amongst individual practices might be identified. The medium to long term aim is to contribute to positively influence the quality of medical care of cancer patients in Germany.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • 18 years and older
  • Tumor disease (carcinoma of either breast, ovary, lung, colon, stomach, pancreas, rectum or plasmacytoma)
  • Written informed consent

Exclusion Criteria: none

Trial design

2,000 participants in 1 patient group

Cancer patients
Description:
Patients suffering from a carcinoma (either breast, ovarian, lung, colon, stomach, pancreas, rectum or plasmacytoma)

Trial contacts and locations

1

Loading...

Central trial contact

Hilde Huber

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems